All NIH Funding Opportunities and Notices

• Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy
  (NOT-OD-18-178)
  Office of the Director, NIH
  

• Notice of Correction to NOT-OD-18-174 "Notice of Intent to Publish a Funding Opportunity Announcement for the Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) Institutional Research Training Program [T32]"
  (NOT-OD-18-193)
  Office of the Director, NIH
  

• Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
  (NOT-OD-18-194)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  

• Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
  (NOT-OD-18-195)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  

• Notice to Extend the Expiration Date for PAR-15-350 "Emerging Directions for Addressing Health Disparities in Alzheimer's Disease (R03)"
  (NOT-AG-18-015)
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  

• Notice to Extend the Expiration Date for PAR-15-357 "Understanding Alzheimer's Disease in the Context of the Aging Brain (R01)"
  (NOT-AG-18-017)
  National Institute on Aging
  

• Notice to Extend the Expiration Date for PAR-15-359 "Novel Approaches to Diagnosing Alzheimer's Disease & Predicting Progression (R01)"
  (NOT-AG-18-019)
  National Institute on Aging
  

• Notice to Extend the Expiration Date for PAR-18-027 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)"
  (NOT-AG-18-020)
  National Institute on Aging
  

• Notice to Extend the Expiration Date for PAR-18-179 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)"
  (NOT-AG-18-021)
  National Institute on Aging
  

• Notice of Clarification of NIA intent to fund awards for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"
  (NOT-AG-18-022)
  National Institute on Aging
  

• Notice of Change to Eligible Organizations in NIAID PAR-18-335 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
  (NOT-AI-18-041)
  National Institute of Allergy and Infectious Diseases
  

• Request for Information (RFI): Evaluation of the NIH Senator Paul D. Wellstone Muscular Dystrophy Research Centers Program
  (NOT-AR-18-021)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  

• Notice of Addition of Letter of Intent Due Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (NOT-EB-18-022)
  National Institute of Biomedical Imaging and Bioengineering
  

• Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
  (NOT-FD-18-012)
  Food and Drug Administration
  

• Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01)
  (NOT-FD-18-013)
  Food and Drug Administration
  

• Notice of U.S. Department of Agriculture (USDA) Participation in PAR-17-482 Comparative Genomics Research Program (R01)
  (NOT-HG-18-007)
  National Human Genome Research Institute
  

• Notice of NIMH's Interest in Studies of Neural Circuitry Linked to Computationally-Defined Behaviors of Relevance to Psychiatry in Rodents and Non-Human Primates
  (NOT-MH-18-036)
  National Institute of Mental Health
  

• Notice of Clarification for Submission of Materials Related to Communications with the FDA for RFA-NS-18-011 "Translational Neural Devices (UG3/UH3 Clinical Trial Required)"
  (NOT-NS-18-063)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-012 "Translational Neural Devices (U44 Clinical Trial Required)"
  (NOT-NS-18-064)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-021 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)"
  (NOT-NS-18-065)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-022 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)"
  (NOT-NS-18-066)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System"
  (NOT-NS-18-067)
  National Institute of Neurological Disorders and Stroke
  

• Notice Regarding New Applications for PAR-15-303: "Occupational Safety and Health Education and Research Centers (42)"
  (NOT-OH-18-008)
  Centers for Disease Control and Prevention
  

• Notice of Pre-Submission Webinars for RFA-TR-18-020: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) and RFA-TR-18-021: Data Management and Coordinating Center (DMCC)
  (NOT-TR-18-029)
  National Center for Advancing Translational Sciences
  

• High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
  (RFA-AG-19-015)
  National Institute on Aging
  Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed)
  (RFA-AG-19-016)
  National Institute on Aging
  Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)
  (RFA-AI-18-026)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): December 13, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
  (RFA-CA-18-025)
  National Cancer Institute
  Application Receipt Date(s): August 28, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
  (PA-18-837)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Application Receipt Date(s): Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date, unless otherwise noted in Institute specific language. Please consult with Scientific contacts listed in Section VII. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed)
  (PAR-18-834)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): September 18, 2018, September 18, 2019, September 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
  (PAR-18-835)
  John E. Fogarty International Center
  National Eye Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 7, 2018; November 7, 2019,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
  (PAR-18-836)
  John E. Fogarty International Center
  National Eye Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 7, 2018; November 7, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892